Tenosynovial Giant Cell Tumor (TGCT) research hub

A clinical trial to learn how an investigational drug (vimseltinib) is absorbed, distributed, broken down, and removed from the body when given to people with liver problems

This study is looking at a new medicine called vimseltinib in people with liver problems. It aims to understand how the body handles the medicine, including how it’s absorbed, spread around, broken down, and removed. This helps researchers work out the safest and most effective way to give it.